These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8617704)

  • 1. The making of a user friendly MAOI diet.
    Gardner DM; Shulman KI; Walker SE; Tailor SA
    J Clin Psychiatry; 1996 Mar; 57(3):99-104. PubMed ID: 8617704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refining the MAOI diet: tyramine content of pizzas and soy products.
    Shulman KI; Walker SE
    J Clin Psychiatry; 1999 Mar; 60(3):191-3. PubMed ID: 10192596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient compliance with MAO inhibitor therapy.
    Walker JI; Davidson J; Zung WW
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):78-80. PubMed ID: 6735998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors.
    Shulman KI; Walker SE; MacKenzie S; Knowles S
    J Clin Psychopharmacol; 1989 Dec; 9(6):397-402. PubMed ID: 2592589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diet and monoamine oxidase inhibitors: a re-examination.
    Sullivan EA; Shulman KI
    Can J Psychiatry; 1984 Dec; 29(8):707-11. PubMed ID: 6394124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clarifying the safety of the MAOI diet and pizza.
    Feinberg S; Holzer B
    J Clin Psychiatry; 2000 Feb; 61(2):145-6. PubMed ID: 10732665
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertensive episode associated with phenelzine and tap beer--a reanalysis of the role of pressor amines in beer.
    Tailor SA; Shulman KI; Walker SE; Moss J; Gardner D
    J Clin Psychopharmacol; 1994 Feb; 14(1):5-14. PubMed ID: 8151003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up?
    Sweet RA; Brown EJ; Heimberg RG; Ciafre L; Scanga DM; Cornelius JR; Dube S; Forsyth KM; Holt CS
    J Clin Psychiatry; 1995 May; 56(5):196-201. PubMed ID: 7737959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary tyramine and other pressor amines in MAOI regimens: a review.
    McCabe BJ
    J Am Diet Assoc; 1986 Aug; 86(8):1059-64. PubMed ID: 3525654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical aspects of MAO inhibitor therapy.
    Davidson J; Zung WW; Walker JI
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):81-4. PubMed ID: 6735999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoamine oxidase inhibitors and food precautions. A comparison of utilization in Belgian psychiatric education institutes and current findings in the literature].
    Mallet L; Schittecatte M
    Acta Psychiatr Belg; 1996; 96(2):74-100. PubMed ID: 8693949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitors: reappraisal of dietary considerations.
    Folks DG
    J Clin Psychopharmacol; 1983 Aug; 3(4):249-52. PubMed ID: 6886038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary consideration in MAO inhibitor regimens.
    McCabe B; Tsuang MT
    J Clin Psychiatry; 1982 May; 43(5):178-81. PubMed ID: 7076627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyramine content of previously restricted foods in monoamine oxidase inhibitor diets.
    Walker SE; Shulman KI; Tailor SA; Gardner D
    J Clin Psychopharmacol; 1996 Oct; 16(5):383-8. PubMed ID: 8889911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyramine and irreversible monoamine oxidase inhibitors in clinical practice.
    Cooper AJ
    Br J Psychiatry Suppl; 1989 Oct; (6):38-45. PubMed ID: 2695126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: the state of the art.
    Rapaport MH
    J Clin Psychiatry; 2007; 68 Suppl 8():42-6. PubMed ID: 17640157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyramine studies and the safety of MAOI drugs.
    Simpson GM; White K
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):59-61. PubMed ID: 6735997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoamine oxidase inhibitor-tyramine interaction.
    Brown C; Taniguchi G; Yip K
    J Clin Pharmacol; 1989 Jun; 29(6):529-32. PubMed ID: 2666453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitors: safety and efficacy issues.
    Brown CS; Bryant SG
    Drug Intell Clin Pharm; 1988 Mar; 22(3):232-5. PubMed ID: 3284731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.